nodes	percent_of_prediction	percent_of_DWPC	metapath
Pipotiazine—ALB—Fluorouracil—urinary bladder cancer	0.164	0.231	CbGbCtD
Pipotiazine—CYP3A4—Thiotepa—urinary bladder cancer	0.158	0.223	CbGbCtD
Pipotiazine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0981	0.138	CbGbCtD
Pipotiazine—ALB—Methotrexate—urinary bladder cancer	0.0905	0.127	CbGbCtD
Pipotiazine—CYP1A2—Etoposide—urinary bladder cancer	0.0819	0.115	CbGbCtD
Pipotiazine—CYP2D6—Doxorubicin—urinary bladder cancer	0.046	0.0647	CbGbCtD
Pipotiazine—CYP3A4—Etoposide—urinary bladder cancer	0.0429	0.0604	CbGbCtD
Pipotiazine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0293	0.0412	CbGbCtD
Pipotiazine—CYP2C19—urine—urinary bladder cancer	0.00915	0.161	CbGeAlD
Pipotiazine—CYP1A2—urine—urinary bladder cancer	0.00748	0.132	CbGeAlD
Pipotiazine—HTR2A—urine—urinary bladder cancer	0.00585	0.103	CbGeAlD
Pipotiazine—CYP3A4—urine—urinary bladder cancer	0.00541	0.0953	CbGeAlD
Pipotiazine—CYP2D6—urine—urinary bladder cancer	0.00533	0.0938	CbGeAlD
Pipotiazine—SLC22A1—renal system—urinary bladder cancer	0.00291	0.0512	CbGeAlD
Pipotiazine—HTR1A—renal system—urinary bladder cancer	0.0024	0.0423	CbGeAlD
Pipotiazine—SLC22A1—vagina—urinary bladder cancer	0.0021	0.0371	CbGeAlD
Pipotiazine—CYP1A2—renal system—urinary bladder cancer	0.00183	0.0322	CbGeAlD
Pipotiazine—CYP2C19—vagina—urinary bladder cancer	0.00162	0.0286	CbGeAlD
Pipotiazine—HTR2A—epithelium—urinary bladder cancer	0.00154	0.0272	CbGeAlD
Pipotiazine—HTR2A—smooth muscle tissue—urinary bladder cancer	0.00149	0.0262	CbGeAlD
Pipotiazine—HTR2A—renal system—urinary bladder cancer	0.00143	0.0252	CbGeAlD
Pipotiazine—CYP3A4—renal system—urinary bladder cancer	0.00132	0.0233	CbGeAlD
Pipotiazine—ALB—lymph node—urinary bladder cancer	0.0013	0.023	CbGeAlD
Pipotiazine—CYP2D6—renal system—urinary bladder cancer	0.0013	0.023	CbGeAlD
Pipotiazine—HTR2A—female reproductive system—urinary bladder cancer	0.00115	0.0202	CbGeAlD
Pipotiazine—CYP3A4—female reproductive system—urinary bladder cancer	0.00106	0.0187	CbGeAlD
Pipotiazine—CYP2D6—female reproductive system—urinary bladder cancer	0.00104	0.0184	CbGeAlD
Pipotiazine—HTR2A—vagina—urinary bladder cancer	0.00104	0.0183	CbGeAlD
Pipotiazine—SLC22A1—Metabolism—GSTP1—urinary bladder cancer	8.22e-05	0.000354	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—JAG1—urinary bladder cancer	8.22e-05	0.000354	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—HPGDS—urinary bladder cancer	8.18e-05	0.000352	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—ENO2—urinary bladder cancer	8.18e-05	0.000352	CbGpPWpGaD
Pipotiazine—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.14e-05	0.00035	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—JAG1—urinary bladder cancer	8.09e-05	0.000348	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—CXCL8—urinary bladder cancer	8.08e-05	0.000347	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.94e-05	0.000342	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—GSTT1—urinary bladder cancer	7.94e-05	0.000341	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	7.93e-05	0.000341	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—NCOR1—urinary bladder cancer	7.93e-05	0.000341	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	7.92e-05	0.000341	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—RHOA—urinary bladder cancer	7.91e-05	0.00034	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	7.84e-05	0.000337	CbGpPWpGaD
Pipotiazine—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.82e-05	0.000336	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—RHOA—urinary bladder cancer	7.77e-05	0.000334	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—IL2—urinary bladder cancer	7.72e-05	0.000332	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—TYMS—urinary bladder cancer	7.65e-05	0.000329	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	7.64e-05	0.000329	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	7.6e-05	0.000327	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—S100B—urinary bladder cancer	7.58e-05	0.000326	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—GSTM1—urinary bladder cancer	7.56e-05	0.000325	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—NCOR1—urinary bladder cancer	7.56e-05	0.000325	CbGpPWpGaD
Pipotiazine—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.43e-05	0.00032	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	7.35e-05	0.000316	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	7.35e-05	0.000316	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—CXCL8—urinary bladder cancer	7.34e-05	0.000316	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.3e-05	0.000314	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	7.3e-05	0.000314	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—GPX1—urinary bladder cancer	7.24e-05	0.000311	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—RHOA—urinary bladder cancer	7.19e-05	0.000309	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	7.16e-05	0.000308	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	7.12e-05	0.000306	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—ERCC2—urinary bladder cancer	7.11e-05	0.000306	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.02e-05	0.000302	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—IL2—urinary bladder cancer	7.01e-05	0.000302	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—TERT—urinary bladder cancer	6.98e-05	0.0003	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—RHOA—urinary bladder cancer	6.95e-05	0.000299	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—CXCL8—urinary bladder cancer	6.95e-05	0.000299	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—RHOA—urinary bladder cancer	6.84e-05	0.000294	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—NCOR1—urinary bladder cancer	6.81e-05	0.000293	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	6.76e-05	0.000291	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	6.76e-05	0.000291	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—MTHFR—urinary bladder cancer	6.68e-05	0.000287	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—S100B—urinary bladder cancer	6.65e-05	0.000286	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—IL2—urinary bladder cancer	6.64e-05	0.000286	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—NQO1—urinary bladder cancer	6.6e-05	0.000284	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	6.55e-05	0.000282	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—S100B—urinary bladder cancer	6.55e-05	0.000282	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—IL2—urinary bladder cancer	6.52e-05	0.00028	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—FGFR3—urinary bladder cancer	6.41e-05	0.000276	CbGpPWpGaD
Pipotiazine—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.4e-05	0.000275	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—RHOA—urinary bladder cancer	6.31e-05	0.000271	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—CXCL8—urinary bladder cancer	6.31e-05	0.000271	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—ESR1—urinary bladder cancer	6.23e-05	0.000268	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—RHOA—urinary bladder cancer	6.21e-05	0.000267	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	6.18e-05	0.000266	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	6.11e-05	0.000263	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—CXCL8—urinary bladder cancer	6.1e-05	0.000262	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—IL2—urinary bladder cancer	6.03e-05	0.000259	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—TERT—urinary bladder cancer	6.01e-05	0.000258	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—CXCL8—urinary bladder cancer	6e-05	0.000258	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—NCOR1—urinary bladder cancer	5.98e-05	0.000257	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	5.92e-05	0.000255	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—NCOR1—urinary bladder cancer	5.89e-05	0.000253	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—EP300—urinary bladder cancer	5.85e-05	0.000251	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—IL2—urinary bladder cancer	5.83e-05	0.000251	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.74e-05	0.000247	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—IL2—urinary bladder cancer	5.73e-05	0.000247	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	5.72e-05	0.000246	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	5.72e-05	0.000246	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.69e-05	0.000245	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—SRC—urinary bladder cancer	5.69e-05	0.000245	CbGpPWpGaD
Pipotiazine—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.58e-05	0.00024	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	5.55e-05	0.000239	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—CXCL8—urinary bladder cancer	5.54e-05	0.000238	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	5.53e-05	0.000238	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—FGFR3—urinary bladder cancer	5.51e-05	0.000237	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—GSTP1—urinary bladder cancer	5.5e-05	0.000237	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.47e-05	0.000235	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CREBBP—urinary bladder cancer	5.46e-05	0.000235	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—CXCL8—urinary bladder cancer	5.45e-05	0.000234	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	5.45e-05	0.000234	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—PPARG—urinary bladder cancer	5.42e-05	0.000233	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—IGF1—urinary bladder cancer	5.39e-05	0.000232	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—EGFR—urinary bladder cancer	5.36e-05	0.000231	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—ESR1—urinary bladder cancer	5.35e-05	0.00023	CbGpPWpGaD
Pipotiazine—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.32e-05	0.000229	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—IL2—urinary bladder cancer	5.29e-05	0.000228	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—TERT—urinary bladder cancer	5.27e-05	0.000227	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—IL2—urinary bladder cancer	5.21e-05	0.000224	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—CREBBP—urinary bladder cancer	5.2e-05	0.000224	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—TERT—urinary bladder cancer	5.19e-05	0.000223	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—TYMS—urinary bladder cancer	5.11e-05	0.00022	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—KRAS—urinary bladder cancer	5.06e-05	0.000218	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—GSTM1—urinary bladder cancer	5.06e-05	0.000217	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—NCOR1—urinary bladder cancer	5.06e-05	0.000217	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.01e-05	0.000216	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	4.94e-05	0.000212	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—RHOA—urinary bladder cancer	4.94e-05	0.000212	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—GPX1—urinary bladder cancer	4.84e-05	0.000208	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—FGFR3—urinary bladder cancer	4.84e-05	0.000208	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.78e-05	0.000206	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	4.77e-05	0.000205	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—FGFR3—urinary bladder cancer	4.76e-05	0.000205	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—ERCC2—urinary bladder cancer	4.75e-05	0.000204	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—KRAS—urinary bladder cancer	4.71e-05	0.000203	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—ESR1—urinary bladder cancer	4.7e-05	0.000202	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CREBBP—urinary bladder cancer	4.69e-05	0.000202	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—IGF1—urinary bladder cancer	4.63e-05	0.000199	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—ESR1—urinary bladder cancer	4.62e-05	0.000199	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	4.61e-05	0.000198	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—EGFR—urinary bladder cancer	4.61e-05	0.000198	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	4.59e-05	0.000198	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—ERBB2—urinary bladder cancer	4.57e-05	0.000197	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	4.54e-05	0.000195	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	4.54e-05	0.000195	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	4.54e-05	0.000195	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.48e-05	0.000193	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—MTHFR—urinary bladder cancer	4.47e-05	0.000192	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	4.42e-05	0.00019	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	4.42e-05	0.00019	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—KRAS—urinary bladder cancer	4.36e-05	0.000187	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	4.35e-05	0.000187	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CXCL8—urinary bladder cancer	4.33e-05	0.000186	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—HRAS—urinary bladder cancer	4.31e-05	0.000185	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	4.28e-05	0.000184	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	4.27e-05	0.000184	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—PTGS2—urinary bladder cancer	4.26e-05	0.000183	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—RHOA—urinary bladder cancer	4.24e-05	0.000183	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	4.22e-05	0.000182	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—TP53—urinary bladder cancer	4.18e-05	0.00018	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	4.17e-05	0.00018	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	4.17e-05	0.00018	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—IL2—urinary bladder cancer	4.14e-05	0.000178	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CREBBP—urinary bladder cancer	4.12e-05	0.000177	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—IGF1—urinary bladder cancer	4.07e-05	0.000175	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CREBBP—urinary bladder cancer	4.05e-05	0.000174	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—EGFR—urinary bladder cancer	4.05e-05	0.000174	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CCND1—urinary bladder cancer	4.04e-05	0.000174	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	4.01e-05	0.000173	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—IGF1—urinary bladder cancer	4e-05	0.000172	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—HRAS—urinary bladder cancer	4e-05	0.000172	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	4e-05	0.000172	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—EGFR—urinary bladder cancer	3.98e-05	0.000171	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—ERBB2—urinary bladder cancer	3.93e-05	0.000169	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	3.92e-05	0.000169	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—MMP9—urinary bladder cancer	3.92e-05	0.000169	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CDKN1A—urinary bladder cancer	3.91e-05	0.000168	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.9e-05	0.000168	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—PTEN—urinary bladder cancer	3.9e-05	0.000168	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	3.85e-05	0.000166	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—KRAS—urinary bladder cancer	3.82e-05	0.000164	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—KRAS—urinary bladder cancer	3.76e-05	0.000162	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—RHOA—urinary bladder cancer	3.73e-05	0.00016	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CXCL8—urinary bladder cancer	3.73e-05	0.00016	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.72e-05	0.00016	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—EP300—urinary bladder cancer	3.72e-05	0.00016	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—PTEN—urinary bladder cancer	3.72e-05	0.00016	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—HRAS—urinary bladder cancer	3.7e-05	0.000159	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	3.69e-05	0.000159	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—RHOA—urinary bladder cancer	3.67e-05	0.000158	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PPARG—urinary bladder cancer	3.62e-05	0.000156	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—SRC—urinary bladder cancer	3.61e-05	0.000155	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	3.58e-05	0.000154	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—IL2—urinary bladder cancer	3.56e-05	0.000153	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	3.56e-05	0.000153	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—EP300—urinary bladder cancer	3.54e-05	0.000152	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	3.54e-05	0.000152	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	3.54e-05	0.000152	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—CREBBP—urinary bladder cancer	3.48e-05	0.00015	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CCND1—urinary bladder cancer	3.47e-05	0.000149	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—ERBB2—urinary bladder cancer	3.45e-05	0.000148	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—ERBB2—urinary bladder cancer	3.39e-05	0.000146	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	3.39e-05	0.000146	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MMP9—urinary bladder cancer	3.37e-05	0.000145	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CDKN1A—urinary bladder cancer	3.36e-05	0.000144	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—PTEN—urinary bladder cancer	3.35e-05	0.000144	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	3.32e-05	0.000143	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CXCL8—urinary bladder cancer	3.27e-05	0.000141	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	3.25e-05	0.00014	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—HRAS—urinary bladder cancer	3.25e-05	0.00014	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—MYC—urinary bladder cancer	3.24e-05	0.000139	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CXCL8—urinary bladder cancer	3.22e-05	0.000138	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—HRAS—urinary bladder cancer	3.2e-05	0.000138	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—EP300—urinary bladder cancer	3.2e-05	0.000137	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—EGFR—urinary bladder cancer	3.17e-05	0.000136	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—IL2—urinary bladder cancer	3.13e-05	0.000134	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	3.13e-05	0.000134	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	3.12e-05	0.000134	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—SRC—urinary bladder cancer	3.11e-05	0.000134	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—IL2—urinary bladder cancer	3.08e-05	0.000132	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CCND1—urinary bladder cancer	3.05e-05	0.000131	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CCND1—urinary bladder cancer	3e-05	0.000129	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—KRAS—urinary bladder cancer	2.99e-05	0.000129	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	2.99e-05	0.000129	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.97e-05	0.000128	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MMP9—urinary bladder cancer	2.96e-05	0.000127	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CDKN1A—urinary bladder cancer	2.95e-05	0.000127	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—PTEN—urinary bladder cancer	2.94e-05	0.000127	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MMP9—urinary bladder cancer	2.91e-05	0.000125	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CDKN1A—urinary bladder cancer	2.9e-05	0.000125	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—PTEN—urinary bladder cancer	2.89e-05	0.000125	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	2.87e-05	0.000124	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PTGS2—urinary bladder cancer	2.85e-05	0.000123	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—EP300—urinary bladder cancer	2.81e-05	0.000121	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MYC—urinary bladder cancer	2.78e-05	0.00012	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	2.76e-05	0.000119	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—EP300—urinary bladder cancer	2.76e-05	0.000119	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	2.73e-05	0.000117	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	2.73e-05	0.000117	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—SRC—urinary bladder cancer	2.73e-05	0.000117	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—EGFR—urinary bladder cancer	2.72e-05	0.000117	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—SRC—urinary bladder cancer	2.68e-05	0.000115	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—TP53—urinary bladder cancer	2.66e-05	0.000114	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	2.61e-05	0.000112	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—KRAS—urinary bladder cancer	2.57e-05	0.000111	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	2.57e-05	0.00011	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	2.56e-05	0.00011	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—HRAS—urinary bladder cancer	2.54e-05	0.000109	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	2.53e-05	0.000109	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PTEN—urinary bladder cancer	2.49e-05	0.000107	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MYC—urinary bladder cancer	2.44e-05	0.000105	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	2.43e-05	0.000105	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	2.41e-05	0.000104	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MYC—urinary bladder cancer	2.41e-05	0.000103	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—EGFR—urinary bladder cancer	2.39e-05	0.000103	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—EP300—urinary bladder cancer	2.37e-05	0.000102	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	2.35e-05	0.000101	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—EGFR—urinary bladder cancer	2.35e-05	0.000101	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—TP53—urinary bladder cancer	2.29e-05	9.84e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—KRAS—urinary bladder cancer	2.26e-05	9.72e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	2.23e-05	9.6e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—KRAS—urinary bladder cancer	2.22e-05	9.56e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—HRAS—urinary bladder cancer	2.19e-05	9.41e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—EP300—urinary bladder cancer	2.13e-05	9.15e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	2.05e-05	8.83e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—TP53—urinary bladder cancer	2.01e-05	8.64e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1.99e-05	8.58e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—TP53—urinary bladder cancer	1.98e-05	8.5e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.96e-05	8.42e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.96e-05	8.41e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—HRAS—urinary bladder cancer	1.92e-05	8.26e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—HRAS—urinary bladder cancer	1.89e-05	8.13e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.88e-05	8.08e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	1.74e-05	7.48e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—EP300—urinary bladder cancer	1.66e-05	7.13e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.54e-05	6.62e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.34e-05	5.77e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.28e-05	5.5e-05	CbGpPWpGaD
